Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Net Asset Value & Final Dividend

21 Apr 2020 17:17

RNS Number : 4086K
Maven Income & Growth VCT PLC
21 April 2020
 

Maven Income and Growth VCT PLC

 

Net Asset Value

 

The Directors of Maven Income and Growth VCT PLC (the Company) confirm that the unaudited net asset value (NAV) of the Company as at 29 February 2020 was 46.35p per Ordinary Share.

 

Subsequent to the year end, having assessed the likely impact across the portfolio from the global COVID-19 pandemic, the Directors announced on 26 March 2020 that, as at 20 March 2020, the unaudited NAV of the Company was 43.49p per share.

 

The NAVs as at 29 February and 20 March 2020 are both unaudited and reflect the closing bid prices of quoted securities as at that date. Investments in unlisted companies are normally valued on a six-monthly basis and the NAV as at 20 March 2020 incorporates the Directors' valuation of unlisted investments as at 29 February 2020, adjusted for subsequent events where appropriate. The Board and the Manager remain in regular contact as they review the evolving COVID-19 situation, and its impact on the Company's portfolio and NAV. Further updates will be provided to Shareholders when required.

 

Final Dividend

 

Whilst your Company does not have a specific dividend target, the Board and the Manager recognise the importance of tax-free distributions to Shareholders and, following recent realisation activity, are pleased to propose a final dividend of 2.00p per Ordinary Share in respect of the year ended 29 February 2020. Subject to Shareholder approval at the 2020 AGM, the final dividend will be paid on 31 July 2020 to Shareholders on the register at 3 July 2020 and will bring total distributions for the year to 4.00p per Ordinary Share.

 

Dividend Investment Scheme (DIS)

 

As announced on 26 March 2020, in light of the current volatility in financial markets caused by the COVID-19 pandemic, the Board had decided that it was appropriate to suspend the DIS. Therefore, until further notice, all subsequent dividends, including the above final distribution proposed in respect of the year ended 29 February 2020, will be paid to all Shareholders by either cheque or by bank transfer using existing mandate instructions. Written confirmation of this suspension in the operation of the DIS will be issued to those Shareholders who have elected to participate.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day close period leading up to the announcement of its annual results for the year ended 29 February 2020 has been notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

21 April 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVKKDBDABKDNQB
Date   Source Headline
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
28th Jan 202511:27 amRNSDirector/PDMR Shareholding
28th Jan 202511:25 amRNSDirector/PDMR Shareholding
28th Jan 202510:39 amRNSIssue of Equity
24th Jan 202511:32 amRNSNet Asset Value(s)
29th Nov 20249:33 amRNSIssue of Equity - Dividend Investment Scheme
26th Nov 20243:51 pmRNSStatement re Dividend Investment Scheme
14th Nov 20242:51 pmRNSResult of General Meeting
24th Oct 20247:00 amRNSHalf-year Report
17th Oct 20244:27 pmRNSTransaction in Own Shares
16th Oct 20244:59 pmRNSTransaction in Own Shares
14th Oct 20243:25 pmRNSUnaudited Net Asset Value and Interim Dividend
27th Sep 20244:31 pmRNSPublication of a Prospectus
5th Sep 20244:45 pmRNSUnaudited Net Asset Value
19th Jul 20242:25 pmRNSIssue of Equity - Dividend Investment Scheme
18th Jul 20244:16 pmRNSTransaction in Own Shares
17th Jul 20245:03 pmRNSTransaction in Own Shares
15th Jul 20243:07 pmRNSStatement re Dividend Investment Scheme
15th Jul 20242:23 pmRNSStatement re Dividend Investment Scheme
12th Jul 20242:56 pmRNSNet Asset Value(s)
11th Jul 20241:38 pmRNSResult of AGM
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
31st May 20244:16 pmRNSFinal Results
16th May 20243:13 pmRNSTransaction in Own Shares
1st May 202410:02 amRNSIssue of Equity
26th Apr 20241:33 pmRNSUnaudited NAV & Proposed Final Dividend
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:47 pmRNSIssue of Equity
27th Mar 202410:34 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
21st Mar 20243:55 pmRNSStatement re Offer for Subscription
20th Mar 20243:44 pmRNSUnaudited Net Asset Value
8th Feb 202410:27 amRNSDirector/PDMR Shareholding
8th Feb 202410:26 amRNSDirector/PDMR Shareholding
8th Feb 202410:08 amRNSIssue of Equity
30th Jan 20245:09 pmRNSTransaction in Own Shares
17th Jan 20249:59 amRNSDirector/PDMR Shareholding
17th Jan 20249:57 amRNSIssue of Equity
15th Jan 20244:25 pmRNSUnaudited Net Value Asset
1st Dec 20239:39 amRNSIssue of Equity
24th Nov 202312:04 pmRNSStatement re Dividend Investment Scheme
9th Nov 20233:35 pmRNSResult of General Meeting
19th Oct 20234:51 pmRNSTransaction in Own Shares
18th Oct 20233:54 pmRNSHalf-year Report
13th Oct 20234:56 pmRNSPublication of a Prospectus
5th Oct 20234:39 pmRNSNet Asset Value and Interim Dividend
20th Jul 20234:32 pmRNSTransaction in Own Shares
14th Jul 20239:26 amRNSIssue of Equity
7th Jul 20234:17 pmRNSStatement re Dividend Investment Scheme
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.